We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Thermo Fisher Scientific to Acquire Transplant Diagnostics Leader One Lambda

By LabMedica International staff writers
Posted on 18 Jul 2012
Thermo Fisher Scientific (Waltham, MA, USA) has signed a definitive agreement to acquire One Lambda (Canoga Park, CA, USA), pioneer and global leader in transplant diagnostics, for USD 925 million in cash. More...
One Lambda, whose business generated revenue of USD 182 million in 2011, will become part of Thermo Fisher’s Specialty Diagnostics Segment.

One Lambda develops its own transplant diagnostic tests utilizing serological, molecular, ELISA, flow, and Luminex xMAP technologies. The company also manufactures laboratory instrumentation and computer software that are used to simplify and automate testing procedures and final test evaluations. The transaction is expected enhance Thermo Fisher's presence in specialty in vitro diagnostics as growth in transplant diagnostics is being driven by increasing global demand. The specialized technology supports a broad portfolio of high-margin reagents in HLA (human leukocyte antigen) typing and antibody detection. New workflow capabilities will be added, as One Lambda's pre- and posttransplant tests will complement Thermo Fisher’s existing immunosuppressant assays. Thermo Fisher expects to leverage its extensive commercial capabilities to accelerate growth in One Lambda’s existing portfolio, which is currently marketed primarily to physicians and laboratories in the USA.

"With its strong technology platform, high margin profile, and good growth prospects, the business is perfectly aligned with our specialty in vitro diagnostics strategy," said Marc N. Casper, president, and chief executive officer of Thermo Fisher. George M. Ayoub, cofounder, president, and chief executive officer of One Lambda, added "I believe that, together, we will […] accelerate growth and improve the success rate of transplantation."

The transaction, anticipated for completion in the fourth quarter of 2012, is expected to be immediately accretive upon close and to generate revenue and cost synergies for a total adjusted operating income benefit of approximately USD 15 million in 2015. Thermo Fisher also announced an authorization to repurchase an additional USD 500 million of shares of its own common stock. “The acquisition of One Lambda […] demonstrates our ongoing commitment to effectively deploying our capital to create shareholder value,” Casper said.

Related Links:

Thermo Fisher Scientific, Inc.
One Lambda, Inc.





Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myocardial Infarction Test
Finecare cTn I/NT-proBNP Rapid Quantitative Test
New
Silver Member
Luteinizing Hormone Test
Luteinizing Hormone (LH) Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: A biomarker discovery pipeline has shown promise as a noninvasive method of diagnosing CRC (Photo courtesy of NCI Center for Cancer Research)

Machine Learning Tool Enables Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States when considering both genders. Colonoscopy remains the gold standard for CRC diagnosis, but it is invasive,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.